After the detection of the common enterobacterial antigen (CA) by Kunin et al. (4) , it was found that only a few enterobacterial strains readily engender CA antibody production in rabbits on intravenous injection of heat-killed bacterial suspensions. In particular, Escherichia coli 014, which was recently characterized as an encapsulated R mutant (17) , and certain other R mutants ofE. coli and Shigella (9, 22) elicit CA antibodies in high titers. In contrast, smooth strains of Enterobacteriaceae fail to engender CA antibodies in appreciable amounts, although they contain the CA determinant and are able to specifically prime the animals for an accelerated immune response (13) . (For the sake of brevity, this form of CA is referred to as "non-immunogenic" CA.) However, CA preparations isolated from these strains and separated from LPS by treatment with 85% aqueous ethanol are highly immunogenic (19) . Recombination of CA and lipopolysaccharide (LPS) in turn markedly reduces CA immunogenicity, provided the two materials are mixed in vitro before intravenous injection (19) . It has been assumed that LPS interacts with CA and possibly causes its deaggregation (21) .
Recently, CA-negative mutants of Salmonella became available (7, 8) , and it was deemed of interest to learn whether LPS of these mutants likewise suppress CA antibody formation. The experiments described here compare the immunosuppressive effects of whole cells and of isolated LPS preparations from both CA-positive and CA-negative enterobacterial strains. In addition, strains belonging to families other than the family Enterobacteriaceae were included in the study.
MATERIALS AND METHODS
The smooth (S) strains and the rough (R) mutants of enteric microorganisms were from the collection of the Max-Planck-Institut fur Immunbiologie, Freiburg, Germany; other strains were obtained from the Center for Disease Control, Atlanta, Ga. They are listed in Table 1 together with appropriate references. They are grouped in three categories: strains producing immunogenic CA, strains producing non- immunogenic CA, and strains that fail to produce CA. In addition to the above microorganisms, nonenteric bacteria such as Pseudomonas aeruginosa and Staphylococcus aureus, which fail to produce CA, were obtained from the collection of Children's Hospital, Buffalo, N.Y., and included in the study.
The strains were grown in Kolle flasks on brain veal agar for 18 h at 37 C. The resulting growth was suspended in 25 ml of phosphate hemagglutination buffer (Difco; pH 7.3) per flask.
LPS obtained from some of the above strains were prepared by the phenol-water method or by the phenol-chloroform-petroleum ether method of Galanos et al. (3) unless indicated otherwise. An additional phenol-water preparation from E. coli 0113 was kindly supplied by Jon A. Rudbach, University of Montana, Missoula. These preparations were dissolved in phosphate hemagglutination buffer at a concentration of 1,000 ,ug/ml and stored at -20 C until used.
Demonstration of CA produced in vitro. For the demonstration of CA produced in vitro by the strains under investigation, the suspension, grown on agar and suspended in phosphate buffer, was heated for 1 h at 100 C. The supernatant obtained after centrifugation at 23 ,500 x g for 20 min was used in the previously described hemagglutination, hemolysis, and hemagglutination inhibition tests (23, 24) . Briefly, washed rabbit erythrocytes (2.5% suspension) were mixed with the supernatant, incubated at 37 C for 30 min, and washed to remove excess antigen. CA antiserum, obtained by immunization of rabbits with E. coli 014, was mixed in twofold serial dilutions (0.2 ml) with equal amounts of the antigenically modified erythrocytes. The mixtures were incubated for 30 min at 37 C, and the resulting hemagglutination was read after centrifugation at 1,300 x g for 2 min. In the passive hemolysis test, 0.1 ml of 1:20 diluted guinea pig complement (Carworth Laboratories, Inc., New York City, N.Y.) was added to the mixture of antiserum and antigenically modified sheep erythrocytes. The resulting hemolysis was read grossly after incubation at 37 C for 30 min. Absence of agglutination and of hemolysis by a high-titered (1:1,280 to 1:5,120) CA antiserum was considered evidence for the absence of CA. The presence of the CA determinant in supernatants of heated bacterial suspensions was further confirmed by a hemagglutination inhibition test, as described previously (24) . Briefly, the supernatant fluid (0.2 ml) was added to 0.2 ml of 2 hemagglutinin units of CA antiserum. The mixtures were incubated in a water bath at 37 C for 30 min. Erythrocytes modified with CA of Salmonella typhimurium (0.2 ml) were then added. The mixtures were reincubated at 37 C for another 30 min, and the resulting hemagglutination was read grossly after centrifugation at 1,300 x g for 2 min. Hemagglutination inhibition was considered evidence for the presence of the CA determinant.
thesize this antigenic determinant. In additional experiments, one part of the suspensions of immunogenic strains was mixed with nine parts of LPS in amounts given below. Unless specified otherwise, the mixtures were heated for 1 h at 100 C and then stored at 4 C until used. Each component alone, in equivalent concentration, was used for control purposes. For immunization, the materials were diluted 1:100 and injected intravenously in 1-ml amounts into albino rabbits weighing between 2 and 3 kg. Injections were given on days 0, 3, 7, and 10. Serum specimens for antibody titration were obtained on days 0, 7, 10, and 14. To determine whether immunological priming resulted from immunization, animals that had failed to respond with a significant increase in CA antibody titers were given a single intravenous booster injection of minimally effective immunogenic CA (1 ml of the ethanol-soluble fraction of S. typhimurium) on day 14, as described previously (13) . For control purposes, nonimmunized rabbits were given the same amount of antigen, and other immunized rabbits without the booster injection were followed in parallel. Sera were obtained 3, 4 and 7 days after the booster injection. The above-described passive hemagglutination was used to titrate CA antibodies. To this end, the serum was titrated in serial twofold dilutions ranging from 1:10 to 1:5,120; rabbit erythrocytes modified with ethanol-soluble CA obtained from S. typhimurium were used as indicator antigen. The mean CA antibody titers of the sera of three rabbits per group are recorded.
RESULTS
In the first series of experiments, a comparison was made of the immunosuppressive activity of strains producing CA and others that do not produce this antigen and certain corresponding LPS (100 ,ug/ml) ( Table 2 ). As immunogen, the immunogenic F3140 (Ri) strain ofS. boydii was used.
It is evident that CA antibody production was inhibited by all CA-producing strains and their LPS but not by the CA-negative strains and their LPS preparations. Nor did the cultures of nonenteric organisms, such as Pseudomonas aeruginosa, Staphylococcus aureus, and Aeromonas hydrophila (20) , which do not synthesize CA, inhibit the antibody response. Essentially identical results were obtained with two other highly immunogenic strains as immunogen, namely, E. coli F2378 (R4) and E. coli F470 (Ri). Experiments not included in Table 2 revealed that all other non-immunogenic, CApositive strains listed in Table 1 were immunosuppressive, in contrast to the CA-negative strains. These results agree with those summarized in Table 2 .
In a second series of experiments, the quantitative aspects of the immunosuppressive effects of LPS were investigated. Using the Rl strain of Shigella boydii F3140 as immunogen, LPS INFECT. IMMUN. from Salmonella minnesota (S1114), when used in amounts of 100 ,tg/ml, completely inhibited CA antibody production; when used in amounts of 20 ,ug/ml only slight inhibition was observed; and with 4 ,ug/ml none was observed (Table 3 ). the bacterial cell remains to be elucidated.
In accord with previous observations (13), immunosuppression was observed after injection of the mixture of CA immunogen and inhibitor only if the two components were mixed in vitro before injection and not when they were injected separately, albeit simultaneously. In a representative experiment the results were as follows: the Rl mutant ofShigella boydii F3140 alone engendered CA antibodies on day 14 in a titer of 1:370; when the mixture of the immunogen and Salmonella minnesota R1000 (Re) was used, the antibody titer was <1:10; and when the two components were injected separately but simultaneously, the antibody titer was 1:320. This experiment also clearly indicates that antigenic competition does not account for the observed immunosuppression. VOL. 13, 1976 on October 11, 2017 by guest http://iai.asm.org/
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To determine whether animals immunized with mixtures of the immunogenic Rl mutant E. coli 08 F470 and the non-immunogenic strain of E. coli 01 were immunologically primed, they were challenged with a minimally effective dose of ethanol-soluble CA of S. typhimurium (Table 4) .
It is evident that immunization with the mixture did prime the animals, for they responded with antibody production in an accelerated and enhanced manner to the booster dose. Essentially identical results were obtained in additional experiments with different strains.
From the above experiments it is evident that a striking difference exists in the immunosuppressive capacity of enteric bacteria and their LPS on the CA antibody response of rabbits, CA-producing, non-immunogenic strains and their LPS being effective in contrast to CAnegative mutants and their LPS. DISCUSSION The original studies of Kunin et al. (4) resulted in the discovery of a hitherto overlooked antigen common to enteric bacteria (CA). Equally important, these authors observed that only a few strains are able to elicit CA antibodies, notably E. coli 014, which was recently characterized as an encapsulated R mutant (17) , and, as shown recently (9, 22) , certain R mutants. CA immunogenicity of whole cells seems to be dependent on a genetically determined association between CA and certain LPS cores of these mutants. Such a close association of LPS core and CA is not observed in the nonimmunogenic, CA-producing strains (11; un- published results). The lack of immunogenicity of the CA determinant in these strains appears to be due to the simultaneous presence of immunosuppressive LPS, for separation of the two antigens by ethanol results in a highly immunogenic CA preparation. In turn, the immunogenicity of the ethanol-soluble preparation can be significantly reduced by LPS as well as by certain other substances (1, 13, 19, 25) . Since it was shown that immunogenic CA preparations and LPS must be mixed in vitro before immunization to obtain this immunosuppressive effect, it appears that the inhibitor interacts with CA to decrease its immunogenicity, although its antibody-binding capacity remains unchanged. It is conceivable that deaggregation of CA is the mechanism, since heat causes a decrease in the immunogenicity of CA and repeated freezing and thawing restores immunogenicity to a large extent (21) . The experiments reported here have revealed that CA-producing, nonimmunogenic strains of microorganisms and their LPS, when mixed with highly immunogenic strains in vitro before immunization, suppress CA antibody production to a significant degree, in contrast to CA-negative strains and their LPS. It remains to be seen whether it is the chemical composition or the particular configuration of the LPS preparations that accounts for these differences. It is noteworthy that the common characteristic of those enterobacterial strains that do not suppress the CA antibody response is a defect in the rfe gene region (Table 1). The function of genes of the rfe cluster is required for the synthesis of CA (7, 8) , of T, (18) , and, in certain Salmonella 0 groups, of 0 chains (6). It is conceivable that, in addition, hitherto unrecognized functions are determined by this gene region that confer to LPS the immunosuppressive properties described above.
The nature of the interaction between LPS and immunogenic CA, either in the form of bacterial cells or of the ethanol-soluble preparation, requires further study. Certainly, LPS is not a specific inhibitor of immunogenic CA, for other substances, such as chlorphenesin and certain lipids, also are effective immunosuppressants in this system (1, 25 A brief comment of historical interest may be added. F. Kauffmann, Copenhagen, Denmark, who established the E. coli typing schema and classified the first 25 serogroups, informed one of us on 2 February 1973 that during these initial investigations he hesitated identifying E. coli 014 as a smooth strain, since it had features of R mutants. Without the inclusion of E. coli 014 in the original serological schema, however, CA may have escaped detection for even longer than 1962.
